Events

This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.

This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.

This live virtual activity will cover the diagnosis, treatment, and management of advanced thyroid cancer.

This program targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use and shared decision-making.

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

This activity will cover the treatment and management of patients with psoriatic arthritis during the COVID-19 pandemic.

This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.

This program targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use and shared decision-making.

This activity will cover the treatment and management of patients with relapsed follicular lymphoma.

This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.